Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

7.210 -0.770 (-9.65%)

Streaming Delayed Price Updated: 10:56 AM EDT, Aug 20, 2026 Add to My Watchlist

Price and Volume

Volume	2,404,244
Open	7.660
Bid (Size)	7.200 (1,100)
Ask (Size)	7.210 (100)
Prev. Close	7.980
Today's Range	7.120 - 7.820
52wk Range	2.960 - 40.37
Shares Outstanding	45,711,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CAPR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

Today 10:40 EDT

From Faruqi & Faruqi LLP

Via GlobeNewswire

CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline

Today 9:20 EDT

From Bernstein Liebhard LLP

Via GlobeNewswire

Performance

YTD	-74.5%	-74.5%
1 Month	-63.0%	-63.0%
3 Month	-75.1%	-75.1%
6 Month	-71.8%	-71.8%
1 Year	-6.0%	-6.0%

More News

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026

August 19, 2026

Via NewMediaWire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 19, 2026

Via Newsfile

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role

August 19, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Investors Face September 28, 2026, Deadline

August 19, 2026

Via NewMediaWire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 18, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Robbins LLP Urges CAPR Stockholders to Contact the Firm for Information About the Class Action Against Capricor Therapeutics, Inc.

August 18, 2026

From Robbins LLP

Via Business Wire

CAPR INVESTOR REMINDER: Capricor Therapeutics, Inc. Investors Have Until September 28, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

August 18, 2026

From Kirby McInerney LLP

Via Business Wire

Kaplan Fox & Kilsheimer LLP Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before September 28, 2026

August 18, 2026

Via NewMediaWire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

August 18, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 18, 2026

Via NewMediaWire

Kaplan Fox Class Action Reminder: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Lead Plaintiff Deadline is September 28, 2026

August 18, 2026

Via NewMediaWire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

August 18, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) is September 28, 2026

August 17, 2026

Via NewMediaWire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 17, 2026

Via Newsfile

Kaplan Fox Advises Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Act Before the Lead Plaintiff Deadline on September 28, 2026

August 17, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

August 17, 2026

Via NewMediaWire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

August 16, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

August 15, 2026

From Pomerantz LLP

Via GlobeNewswire

Kaplan Fox Deadline Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Have Until September 28, 2026 to Seek a Lead Plaintiff Role

August 14, 2026

Via NewMediaWire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 14, 2026

Via Newsfile

Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

August 14, 2026

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 14, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

August 14, 2026

Via Chartmill

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?

Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?

Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?

The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market

What is the current price of Capricor Therapeutics, Inc. - Common Stock?

The current price of Capricor Therapeutics, Inc. - Common Stock is 7.210

When was Capricor Therapeutics, Inc. - Common Stock last traded?

The last trade of Capricor Therapeutics, Inc. - Common Stock was at 08/20/26 10:56 AM ET

What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?

The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 329.58M

How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?

Capricor Therapeutics, Inc. - Common Stock has 330M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.